Texas Transplant Institute   Report issue

Academic/Hospital Phase 2 Phase 3
Founded: San Antonio TX United States

Organization Overview

First Clinical Trial
1999
NCT00029380
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Texas Transplant Institute